Mirae Asset Global Investments Co., Ltd. Terns Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,374 shares of TERN stock, worth $29,218. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,374
Previous 2,842
18.72%
Holding current value
$29,218
Previous $7,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TERN
# of Institutions
133Shares Held
84.2MCall Options Held
173KPut Options Held
89.5K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$70.7 Million2.36% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$65.5 Million1.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$64.9 Million0.99% of portfolio
-
Morgan Stanley New York, NY7.25MShares$62.8 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$59.7 Million5.45% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $326M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...